OZEM
Roundhill GLP-1 & Weight Loss ETF · NAS
- Category Equity
- Expense Ratio 0.59%
- Listing Date May 21, 2024
- Volume 21,541.0
- Market Cap (AUM) $45.28M
Performance
-4.16%
1W
+6.65%
1M
+5.26%
3M
+9.11%
6M
+9.11%
YTD
+9.11%
1Y
Top Holdings
-
Name
Symbol%Assets
- Eli Lilly and CompanyLLY21.50%
- Novo Nordisk A/S Sponsored ADR Class BNVO20.04%
- Amgen Inc.AMGN4.44%
- Chugai Pharmaceutical Co., Ltd.45194.27%
- Zealand Pharma A/SZEAL3.86%
- Innovent Biologics, Inc.18013.73%
- Roche Holding Ltd Dividend Right Cert.ROG3.44%
- Astrazeneca PLC Sponsored ADRAZN3.34%
- Hanmi Pharmaceutical Co., Ltd.1289402.80%
- Viking Therapeutics, Inc.VKTX2.61%
Recent News & Updates
- 2024-05-21 09:00
- 2024-05-20 21:00
Page 1 of 1
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.